webinar register page

Webinar banner
Insights from Autopsy-Based Clinicopathological Correlation of COVID-19: Pathology, Mechanisms, and Treatment Strategies
Drs. Buja and Vander Heide discuss what we know and what remains to be elucidated about COVID-19.

1. Discuss the epidemiology and major trends in the pandemic
2. Describe the key pathological findings in cases of severe COVID-19
3. Discuss implications of the pathological findings for pathophysiology and pathogenesis of the disease
4. Discuss implications of the pathological findings for therapy and prevention of the disease

Mar 10, 2021 11:30 AM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



L. Maximilian Buja, MD
Professor of Pathology and Laboratory Medicine @The University of Texas Health Sciences Center at Houston
Dr. Buja is engaged in scholarly investigation, educational activities and clinical service while also serving in leadership roles. His subspecialty interest is cardiovascular pathology with research interests in myocardial cell injury, myocardial ischemia, atherosclerosis and cardiomyopathies. Dr. Buja teaches medical students, medical residents, clinical fellows, graduate students and research post-doctoral fellows. He also conducts a clinical practice in cardiovascular pathology providing staffing of autopsy cases and surgical pathology consultation of cardiac and vascular cases and interpretation of myocardial biopsies from referrals. He directs a cardiovascular pathology fellowship approved by the Texas Medical Board. Since the establishment of an Advanced Heart Failure Center on campus, he has served as the cardiovascular pathologist for the Center and has provided staffing for over 100 heart transplants, numerous LVADs, and post-transplant myocardial biopsies.
Richard Vander Heide, MD, PhD, MBA
Professor @LSU Health School of Medicine
Dr. Vander Heide completed his residency in Anatomic Pathology at Duke University from 1989-1993. His first position was at Wayne State University Medical School in Detroit, Michigan where he was the Residency Program Director for 5 years and was named as Best Pathology instructor by the sophomore medical student class 3 times. He was Chief of Pathology at the John D. Dingell VA Medical Center from 2000-2009. His primary research interest is myocardial cell injury and adaptation; specifically in response to ischemia/reperfusion injury. Dr. Vander Heide's clinical interests include cardiovascular pathology, autopsy pathology, and COVID-19.